KOL KnockoutTM: Glaucoma Edition - Personalized Treatment Pl

Name: KOL Knockout™: Glaucoma Edition - Personalized Treatment Plans in Medical Glaucoma Management - Round 2
Uploaded: 2021-12-03T05:00:00+00:00
Duration: 1 h 19 min 20 s
Description: Round 2 of this fun and exciting virtual CME program, hosted by Douglas Rhee, MD, is a game show-style quiz competition that will feature Round 1 Champion

Overview
Round 2 of this fun and exciting virtual CME program, hosted by Douglas Rhee, MD, is a game show-style quiz competition that will feature Round 1 Champion Jody Piltz-Seymour, MD, along with two new KOL contestants: JoAnn Giaconi, MD, and Thomas D. Patrianakos, DO.
The program includes a brief presentation followed by patient case studies and each KOL will weigh in on the treatment options. Will Dr. Piltz-Seymour keep her winning title or will Drs. Giaconi or Patrianakos take the belt? Watch to find out!
There will be learning, laughter, and only one KOL left standing!
This content was captured during a live virtual symposium. Voting took place during the symposium.
This activity is supported by an unrestricted educational grant from Aerie Pharmaceuticals.
Learning Objectives
Upon completion of this activity, the participant should be able to:
- Describe the MOA of novel therapeutics and classes of drugs.
- Discuss the differences of branded versus generic glaucoma agents and identify patients at heightened risk for loss to follow-up.
- Evaluate and explain to patients the latest available treatments and determine which option is best for each patient.
- Restate the most common side effects of novel therapeutics and explain the likelihood of achieving target intraocular pressure with monotherapy compared with combination regimens.
Participation Method
In order to obtain credit, proceed through the program, complete the post-test, evaluation and submit for credit.
Faculty and Disclosures
Douglas J. Rhee, MD
Chair, Department of Ophthalmology and Visual Sciences
Director, University Hospitals Eye Institute
Case Western Reserve University School of Medicine
Cleveland, OH

JoAnn Giaconi, MD
Health Sciences Professor of Ophthalmology
Jules Stein Eye Institute
David Geffen School of Medicine
University of California, Los Angeles
Chief of Ophthalmology
Veterans Administration Hospital
of Greater Los Angeles
Los Angeles, CA

Thomas D. Patrianakos, DO
Chair of Ophthalmology
Cook County Health
Chicago, IL

Jody Piltz-Seymour, MD
Valley Eye Professionals, LLC
Wills Eye Hospital Glaucoma Service
Clinical Professor, Perelman School of Medicine, University of Pennsylvania
Philadelphia, PA

DISCLOSURE POLICY
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflicts of interest relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all conflicts of interest prior to this educational activity.
The following faculty/staff members have the following financial relationships with commercial interests:
Douglas J. Rhee, MD, has had a financial agreement or affiliation with the following ineligible companies in the form of Advisory Board: Ocular Therapeutix. Consultant: Aerie Pharmaceuticals, Allergan, and Ivantis. Grant/Research Support: Allergan, Glaukos, and Ivantis. Speaker’s Bureau: Aerie and Ivantis.
JoAnn Giaconi, MD, has had a financial agreement or affiliation during the past year ith the following ineligible companies in the form of Consultant and Speaker’s Bureau: Allergan.
Thomas D. Patrianakos, DO, has had no financial agreements or affiliations with ineligible companies.
Jody Piltz-Seymour, MD, has had a financial agreement or affiliation during the past year with the following inelegible companies in the form of Consultant and Speaker's Bureau: Aerie Pharmaceuticals.
The Evolve staff, planners and peer reviewer have no financial relationships with commercial interests.
Disclaimer
OFF-LABEL STATEMENT
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
DISCLAIMER
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve or Aerie Pharmaceuticals.
System Requirements
- Supported Browsers (2 most recent versions):
- Google Chrome for Windows, Mac OS, iOS, and Android
  Apple Safari for Mac OS and iOS
  Mozilla Firefox for Windows, Mac OS, iOS, and Android
  Microsoft Edge for Windows
- Recommended Internet Speed: 5Mbps+
Publication Dates
Release Date: 12/03/2021